Panelists discuss how Bruton tyrosine kinase (BTK) inhibitors have transformed the treatment paradigm for patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL ...

Patient-Centered Selection of BTK Inhibitors: Balancing Clinical Factors and Patient Preferences EP: 16 . Implementation of Shared Decision-Making in BTK Inhibitor Treatment ...

BTK inhibitors, including the commonly used drug ibrutinib, block B cells' signaling pathway. This is helpful for treating B-cell lymphomas because the cancers arise when this signaling pathway ...